0000950123-17-009437.txt : 20171103 0000950123-17-009437.hdr.sgml : 20171103 20171102192357 ACCESSION NUMBER: 0000950123-17-009437 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171103 DATE AS OF CHANGE: 20171102 EFFECTIVENESS DATE: 20171103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharmstandard International S.A. CENTRAL INDEX KEY: 0001598762 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17790 FILM NUMBER: 171174229 BUSINESS ADDRESS: STREET 1: 10A, RUE HENRI SCHNADT CITY: LUXEMBOURG STATE: N4 ZIP: L-2530 BUSINESS PHONE: 352 24840131 MAIL ADDRESS: STREET 1: 10A, RUE HENRI SCHNADT CITY: LUXEMBOURG STATE: N4 ZIP: L-2530 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001598762 XXXXXXXX 09-30-2017 09-30-2017 Pharmstandard International S.A.

10A, RUE HENRI SCHNADT LUXEMBOURG N4 L-2530

13F HOLDINGS REPORT 028-17790 N Eriks Martinovskis 352 24840131 /s/ Eriks Martinovskis Luxembourg N4 11-02-2017 1 5 34304 false 1 Joint Stock Co Pharmstandard INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Argos Therapeutics Inc. Common 040221103 2377 13242279 SH DFND 1 0 13242279 0 Argos Therapeutics Inc. Common 040221103 919 5120604 SH Call DFND 1 0 5120604 0 Proteon Therapeutics Inc. Common 74371L109 3336 1667907 SH DFND 1 0 1667907 0 Protagonist Therapeutics, Inc. Common 74366E102 17357 982270 SH DFND 1 0 982270 0 Jounce Therapeutics, Inc. Common 481116101 10315 662063 SH DFND 1 0 662063 0